When your research has the potential to save lives, you deserve a partner with the oncology pharmacology knowledge, breadth of tools and experience to help move life-changing drug candidates through preclinical development and beyond quickly and effectively.
Our preclinical oncology solutions consist of in vitro and in vivo pharmacology efficacy models, in vivo imaging technologies, in vitro assessments and focal radiation capabilities to support your oncology research programs. Our team helps you explore the effects of drugs and biologics using both human and syngeneic tumor models providing you with decision-driving data to help advance your drug candidate toward the next cancer research breakthrough.
Take advantage of the widest breadth of analysis tools and models in the industry.
Access a full suite of molecular and cellular biology assays.
Explore our comprehensive list of oncological cell lines.
GeoMx® Digital Spatial Profiler (DSP)
We offer over 50 different syngeneic tumor models, from both solid and disseminated origins, to provide you with many choices to further your immuno-oncology research. We are continually improving and expanding our adoptive cell therapy capabilities.
For over a decade, we have offered an industry-leading array of technology platforms to deliver efficient quality results:
Expedite your candidate selection with quick start times, expert scientific collaboration and innovative science.
To understand how anticancer therapeutics behave in patients, we need preclinical oncology models that mimic actual human tissue. Reduce the failure rate of your candidate anticancer trials with our advances in tumor-specific 3D
The fight against cancer starts in the lab. That’s why we’ve invested in a renovation that doubled the size of our preclinical oncology facility in Ann Arbor, Michigan. Here you can discover enhanced capabilities and greater capacity to speed up your preclinical oncology programs.
View in-depth analysis, including growth curves and treatment response, for preclinical tumor models and technology in our model and tech spotlights.
